Showing results (1611-1620 of 8,402) with videos related to

Sort By:
Pageof 841
Health Affairs (Project Hope)|February 11, 2012
Adjusting for risk selection in state health insurance exchanges will be critically important and feasible, but not easyJonathan P Weiner, Erin Trish, Chad Abrams, et al.
Neurorehabilitation and Neural Repair|September 11, 2008
Functional outcomes can vary by dose: learning-based sensorimotor training for patients stable poststrokeNancy N Byl, Erica A Pitsch, Gary M Abrams
African Journal of Emergency Medicine : Revue Africaine De La Medecine D'Urgence|June 14, 2019
Dissemination patterns of scientific abstracts presented at the first and second African Conference of Emergency MedicineMarlin Abrams, Stevan R Bruijns, Daniël J van Hoving
Ground Water|July 11, 2019
Modeling a Large-Scale Historic Aquifer Test: Insight into the Hydrogeology of a Regional Fault ZoneDaniel R Hadley, Daniel B Abrams, George S Roadcap
Health Science Reports|October 14, 2021
Drexit: Understanding why junior doctors leave their training programs to train overseas: An observational study of UK physiciansHannah C P Wilson, Sarah Abrams, Arabella Simpkin Begin
Journal of Clinical Pharmacology|July 1, 1978
Controlled clinical trial of sedative-anticholinergic drugs in patients with the irritable bowel syndromeJ B Rhodes, J H Abrams, R T Manning
Statistics in Medicine|December 21, 2000
Hierarchical models in generalized synthesis of evidence: an example based on studies of breast cancer screeningT C Prevost, K R Abrams, D R Jones
Diseases of the Colon and Rectum|April 1, 1984
A new type of continent ileostomy. Results of an animal studyG R Orangio, B Bronsther, M Abrams, et al.
The International Journal of Eating Disorders|July 1, 1993
Disordered eating attitudes and behaviors, psychological adjustment, and ethnic identity: a comparison of black and white female college studentsK K Abrams, L R Allen, J J Gray
Molecular Medicine (Cambridge, Mass.)|November 1, 1995
Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulationK Gijbels, S Brocke, J S Abrams, et al.
Pageof 841